unknown
Stage
About
Atterx Biotherapeutics develops novel treatments aimed at preventing and treating antibiotic-resistant bacterial infections, including solutions targeting catheter-associated urinary tract infections and gram-negative bacterial infections.
Explore Atterx Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.